198 related articles for article (PubMed ID: 24189203)
1. A stable isotope-labeled internal standard is essential for correcting for the interindividual variability in the recovery of lapatinib from cancer patient plasma in quantitative LC-MS/MS analysis.
Wu J; Wiegand R; LoRusso P; Li J
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 941():100-8. PubMed ID: 24189203
[TBL] [Abstract][Full Text] [Related]
2. Sensitive single quadrupole LC/MS method for determination of lapatinib in human plasma.
Musijowski J; Filist M; Rudzki PJ
Acta Pol Pharm; 2014; 71(6):1029-36. PubMed ID: 25745775
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a stable isotope labeled (SIL) peptide and an extended SIL peptide as internal standards to track digestion variability of an unstable signature peptide during quantification of a cancer biomarker, human osteopontin, from plasma using capillary microflow LC-MS/MS.
Faria M; Halquist MS; Yuan M; Mylott W; Jenkins RG; Karnes HT
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1001():156-68. PubMed ID: 26279007
[TBL] [Abstract][Full Text] [Related]
4. A sensitive LC-MS-MS assay for the determination of lapatinib in human plasma in subjects with end-stage renal disease receiving hemodialysis.
Kocan GP; Huang MQ; Li F; Pai S
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Oct; 1097-1098():74-82. PubMed ID: 30205234
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
Haouala A; Zanolari B; Rochat B; Montemurro M; Zaman K; Duchosal MA; Ris HB; Leyvraz S; Widmer N; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):1982-96. PubMed ID: 19505856
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC/MS/MS.
Andriamanana I; Gana I; Duretz B; Hulin A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 926():83-91. PubMed ID: 23562906
[TBL] [Abstract][Full Text] [Related]
7. LC-MS/MS determination of a human mAb drug candidate in rat serum using an isotopically labeled universal mAb internal standard.
Li W; Lin H; Fu Y; Flarakos J
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1044-1045():166-176. PubMed ID: 28113139
[TBL] [Abstract][Full Text] [Related]
8. Micromethod for quantification of cinacalcet in human plasma by liquid chromatography-tandem mass spectrometry using a stable isotope-labeled internal standard.
Cangemi G; Barco S; Verrina EE; Scurati S; Melioli G; Della Casa Alberighi O
Ther Drug Monit; 2013 Feb; 35(1):112-7. PubMed ID: 23222688
[TBL] [Abstract][Full Text] [Related]
9. Ultrafast Online SPE-MS/MS Method for Quantification of 3 Tyrosine Kinase Inhibitors in Human Plasma.
Vrobel I; Janečková H; Faber E; Bouchalová K; Mičová K; Friedecký D; Adam T
Ther Drug Monit; 2016 Aug; 38(4):516-24. PubMed ID: 27414975
[TBL] [Abstract][Full Text] [Related]
10. Liquid chromatography/tandem mass spectrometry methods for quantitation of mevalonic acid in human plasma and urine: method validation, demonstration of using a surrogate analyte, and demonstration of unacceptable matrix effect in spite of use of a stable isotope analog internal standard.
Jemal M; Schuster A; Whigan DB
Rapid Commun Mass Spectrom; 2003; 17(15):1723-34. PubMed ID: 12872277
[TBL] [Abstract][Full Text] [Related]
11. A validated LC-MS/MS assay for the simultaneous determination of the anti-leukemic agent dasatinib and two pharmacologically active metabolites in human plasma: application to a clinical pharmacokinetic study.
Furlong MT; Agrawal S; Hawthorne D; Lago M; Unger S; Krueger L; Stouffer B
J Pharm Biomed Anal; 2012 Jan; 58():130-5. PubMed ID: 21982905
[TBL] [Abstract][Full Text] [Related]
12. Determination of rifalazil, a potent antibacterial agent, in human plasma by liquid-liquid extraction and LC-MS/MS.
Larsson M; Michaelis AF; Zhu Y; Ramu K
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(1):103-10. PubMed ID: 17936092
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a method for gefitinib quantification in dried blood spots using liquid chromatography-tandem mass spectrometry: Application to finger-prick clinical blood samples of patients with non-small cell lung cancer.
Irie K; Shobu S; Hiratsuji S; Yamasaki Y; Nanjo S; Kokan C; Hata A; Kaji R; Masago K; Fujita S; Okada Y; Katakami N; Fukushima S
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1087-1088():1-5. PubMed ID: 29689441
[TBL] [Abstract][Full Text] [Related]
14. Isotope-labeled versus analog internal standard in LC-MS/MS method for tacrolimus determination in human whole blood samples - A compensation of matrix effects.
Bodnar-Broniarczyk M; Pawiński T; Kunicki PK
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1104():220-227. PubMed ID: 30530114
[TBL] [Abstract][Full Text] [Related]
15. Suitability of a fully 13C isotope labeled internal standard for the determination of the mycotoxin deoxynivalenol by LC-MS/MS without clean up.
Häubl G; Berthiller F; Krska R; Schuhmacher R
Anal Bioanal Chem; 2006 Feb; 384(3):692-6. PubMed ID: 16362816
[TBL] [Abstract][Full Text] [Related]
16. Liquid chromatography tandem mass spectrometry method for determination of N-acetylcysteine in human plasma using an isotope-labeled internal standard.
Lu C; Liu G; Jia J; Gui Y; Liu Y; Zhang M; Liu Y; Li S; Yu C
Biomed Chromatogr; 2011 Apr; 25(4):427-31. PubMed ID: 21374646
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous quantitative analysis of letrozole, its carbinol metabolite, and carbinol glucuronide in human plasma by LC-MS/MS.
Precht JC; Ganchev B; Heinkele G; Brauch H; Schwab M; Mürdter TE
Anal Bioanal Chem; 2012 Apr; 403(1):301-8. PubMed ID: 22367241
[TBL] [Abstract][Full Text] [Related]
18. Validation and determination of taselisib, a β-sparing phosphoinositide 3-kinase (PI3K) inhibitor, in human plasma by LC-MS/MS.
Ding X; Faber K; Shi Y; McKnight J; Dorshorst D; Ware JA; Dean B
J Pharm Biomed Anal; 2016 Jul; 126():117-23. PubMed ID: 27187764
[TBL] [Abstract][Full Text] [Related]
19. Liquid chromatography/tandem mass spectrometry for the determination of changrolin in rat plasma: application to a bioavailability study.
Yang D; Yu C; Li S; Liu G; Lu Y; Wang Y
J Pharm Biomed Anal; 2009 Sep; 50(2):189-93. PubMed ID: 19467818
[TBL] [Abstract][Full Text] [Related]
20. A new reliable, transposable and cost-effective assay for absolute quantification of total plasmatic bevacizumab by LC-MS/MS in human plasma comparing two internal standard calibration approaches.
Legeron R; Xuereb F; Chaignepain S; Gadeau AP; Claverol S; Dupuy JW; Djabarouti S; Couffinhal T; Schmitter JM; Breilh D
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Dec; 1070():43-53. PubMed ID: 29111437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
